Kevin Lord

716 total citations
17 papers, 548 citations indexed

About

Kevin Lord is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin Lord has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin Lord's work include Neurotransmitter Receptor Influence on Behavior (3 papers), Forensic Toxicology and Drug Analysis (3 papers) and Advanced Breast Cancer Therapies (2 papers). Kevin Lord is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (3 papers), Forensic Toxicology and Drug Analysis (3 papers) and Advanced Breast Cancer Therapies (2 papers). Kevin Lord collaborates with scholars based in United States, Australia and Germany. Kevin Lord's co-authors include Kurt J. Varner, Pamela A. Lucchesi, James A. Stewart, Sylvia Shenouda, Mary J. Cismowski, Kirk R. Hutchinson, Aaron J. Trask, Paige S. Katz, Flavia M. Souza‐Smith and Suzanne Meleg-Smith and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Applied Physiology.

In The Last Decade

Kevin Lord

15 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Lord United States 11 156 112 75 74 51 17 548
J. A. Arruda United States 19 108 0.7× 442 3.9× 89 1.2× 81 1.1× 152 3.0× 67 1.0k
Xueli Cai China 16 122 0.8× 83 0.7× 4 0.1× 19 0.3× 128 2.5× 52 655
Fu Liang Ng United Kingdom 14 212 1.4× 295 2.6× 3 0.0× 48 0.6× 33 0.6× 25 693
Hyun Joung Lim South Korea 12 154 1.0× 242 2.2× 8 0.1× 33 0.4× 46 0.9× 20 776
Svetlana Slavić Austria 12 298 1.9× 409 3.7× 4 0.1× 28 0.4× 99 1.9× 19 1.2k
Guofeng Gao China 16 182 1.2× 376 3.4× 5 0.1× 75 1.0× 45 0.9× 46 790
Yoshiaki Fujii Japan 11 28 0.2× 116 1.0× 7 0.1× 34 0.5× 76 1.5× 41 461
F. S. Hough South Africa 15 21 0.1× 354 3.2× 14 0.2× 18 0.2× 42 0.8× 31 878
Nadia Sawicka‐Gutaj Poland 16 27 0.2× 197 1.8× 4 0.1× 10 0.1× 37 0.7× 90 884
Ruixia Zhu China 21 50 0.3× 630 5.6× 3 0.0× 47 0.6× 99 1.9× 90 1.3k

Countries citing papers authored by Kevin Lord

Since Specialization
Citations

This map shows the geographic impact of Kevin Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Lord more than expected).

Fields of papers citing papers by Kevin Lord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Lord. The network helps show where Kevin Lord may publish in the future.

Co-authorship network of co-authors of Kevin Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Lord. A scholar is included among the top collaborators of Kevin Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Lord. Kevin Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Altomare, Ivy, Shreekant Parasuraman, Dilan Paranagama, et al.. (2021). Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea. Clinical Lymphoma Myeloma & Leukemia. 21(11). e915–e921. 8 indexed citations
2.
Shehata, Ghaydaa A., et al.. (2021). Neurological Complications of COVID-19: Underlying Mechanisms and Management. International Journal of Molecular Sciences. 22(8). 4081–4081. 49 indexed citations
3.
Feinberg, Bruce A., et al.. (2020). Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis. The Oncologist. 25(4). 319–326. 6 indexed citations
4.
Feinberg, Bruce A., et al.. (2019). Reports of the demise of chemotherapy have been greatly exaggerated.. PubMed. 25(6). 270–272. 5 indexed citations
5.
Attridge, Rebecca L., et al.. (2017). Using admissions criteria for predicting student failure outcomes of supplemental instruction and remediation in a Doctor of Pharmacy programme. Pharmacy Education. 17.
6.
Lord, Kevin, David Moll, Girija Raman, et al.. (2011). Environmentally persistent free radicals decrease cardiac function before and after ischemia/reperfusion injuryin vivo. Journal of Receptors and Signal Transduction. 31(2). 157–167. 57 indexed citations
7.
Souza‐Smith, Flavia M., Paige S. Katz, Aaron J. Trask, et al.. (2011). Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling. PLoS ONE. 6(8). e23337–e23337. 38 indexed citations
8.
Katz, Paige S., Aaron J. Trask, Flavia M. Souza‐Smith, et al.. (2011). Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Research in Cardiology. 106(6). 1123–1134. 61 indexed citations
9.
Hutchinson, Kirk R., Anuradha Guggilam, Mary J. Cismowski, et al.. (2011). Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. Journal of Applied Physiology. 111(6). 1778–1788. 49 indexed citations
10.
Lord, Kevin, et al.. (2010). Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovascular Research. 87(1). 111–118. 62 indexed citations
11.
Zerfaoui, Mourad, Amarjit S. Naura, Youssef Errami, et al.. (2009). Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy antigen receptor for chemokines. Journal of Leukocyte Biology. 86(6). 1385–1392. 28 indexed citations
12.
Shenouda, Sylvia, et al.. (2008). Ecstasy produces left ventricular dysfunction and oxidative stress in rats. Cardiovascular Research. 79(4). 662–670. 27 indexed citations
13.
Blumer, J, Kevin Lord, Thomas L. Saunders, et al.. (2008). Activator of G‐protein Signaling 3 null mice: unexpected alterations in metabolic and cardiovascular function. The FASEB Journal. 22(S1).
14.
Blumer, J, Kevin Lord, Thomas L. Saunders, et al.. (2008). Activator of G Protein Signaling 3 Null Mice: I. Unexpected Alterations in Metabolic and Cardiovascular Function. Endocrinology. 149(8). 3842–3849. 54 indexed citations
15.
Lord, Kevin, et al.. (2002). Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited during Binge Administration of Ecstasy. Journal of Pharmacology and Experimental Therapeutics. 302(3). 898–907. 59 indexed citations
16.
Lord, Kevin, et al.. (2002). Pulmonary capillary pressure during acute lung injury in dogs. Critical Care Medicine. 30(2). 403–409. 7 indexed citations
17.
Gaffney, P.J., M. Brasher, Kevin Lord, et al.. (1976). Fibrin subunits in venous and arterial thromboembolism. Cardiovascular Research. 10(4). 421–426. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026